Shanghai Institutes for Biological Sciences, Cas
Records under this name other than the patents Shanghai Institutes for Biological Sciences, Cas holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 1 patents it holds.
Showing 1 to 10 of 10 · Back to Shanghai Institutes for Biological Sciences, Cas
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,693,555 | Insect-combating preparation and method based on RNAi technology Formerly held In force · USPTO record | In force | USPTO record | |
| US 9,682,954 | Phenanthridine derivatives, preparation methods and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 10,112,918 | 15-oxospiramilactone derivatives, preparation method and uses thereof Formerly held In force · USPTO record | In force | USPTO record | |
| US 7,544,485 | Baldness Related Gene and the Polypeptide Encoded Thereby , and Uses Formerly held Term ended Term ended Jul 9, 2024 · High confidence | Term ended | Term ended Jul 9, 2024 | High confidence |
| US 10,155,958 | Method for improving plant resistance to insects Formerly held Lapsed on the fee record Ended Dec 18, 2022 · USPTO record | Lapsed on the fee record | Ended Dec 18, 2022 | USPTO record |
| US 7,803,563 | Method for Screening the Receptor-Ligand Binding in Live Cell Lapsed on the fee record Ended Sep 28, 2022 · High confidence | Lapsed on the fee record | Ended Sep 28, 2022 | High confidence |
| US 8,536,121 | Methods and reagents for the diagnosis, prevention and treatment of insulin resistance using beta-arrestin2 and its up-regulators Lapsed on the fee record Ended Sep 17, 2021 · USPTO record | Lapsed on the fee record | Ended Sep 17, 2021 | USPTO record |
| US 8,461,419 | Plant height regulatory gene and uses thereof Lapsed on the fee record Ended Jun 11, 2021 · USPTO record | Lapsed on the fee record | Ended Jun 11, 2021 | USPTO record |
| US 8,193,162 | Human Liver Regeneration Associated Protein and the Use Thereof Lapsed on the fee record Ended Jun 5, 2020 · High confidence | Lapsed on the fee record | Ended Jun 5, 2020 | High confidence |
| US 7,939,497 | Detection and modulation of slit and roundabount (robo) mediated angiogenesis and uses thereof Lapsed on the fee record Ended May 10, 2019 · USPTO record | Lapsed on the fee record | Ended May 10, 2019 | USPTO record |